{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-012986","form_type":"8-K","ticker":"BKYI","cik":"0001019034","company_name":"BIO KEY INTERNATIONAL INC","filed_at":"2025-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.161670+00:00","generated_at":"2026-05-23T06:36:10.666405+00:00","sec_items":["3.01","7.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"BIO-key regains Nasdaq compliance after late 10-K filing","bullets":["Received Nasdaq non-compliance notice on April 17, 2025, for failure to timely file Form 10-K.","Filed the missing 10-K on April 23, 2025.","Nasdaq confirmed compliance on April 24, 2025, closing the matter.","No immediate effect on stock listing or trading during the period."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-012986","json":"https://secwatch.observer/filing/0001437749-25-012986.json","markdown":"https://secwatch.observer/filing/0001437749-25-012986.md","text":"https://secwatch.observer/filing/0001437749-25-012986.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1019034/000143774925012986/0001437749-25-012986-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1019034/000143774925012986/bkyi20250424_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T06:36:10.666405+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"91bdfac728b1ba33080017de36607dcc0138db7d","claim":"BIO KEY INTERNATIONAL INC received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"April 17, 2025, BIO-key International, Inc. (the “ Company ”) received notice from The Nasdaq Stock Market, LLC (“ Nasdaq ”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (“ SEC ”), due to the Company’s failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2024 (the “ Form 10-K ”). The notification letter has no immediate effect on the listing or trading of the Company’s common stock on the Na","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1019034/000143774925012986/0001437749-25-012986-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"noncompliance notice"},{"label":"Deficiency","value":"late filing"},{"label":"Rules","value":"5250(c)(1)"}],"fact_type":"exchange_compliance_notice"},{"claim_id":"bbf4ff8401c798155e362b109eaf12080c119047","claim":"BIO KEY INTERNATIONAL INC received a nasdaq compliance regained notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"April 24, 2025, the Company received notice from Nasdaq stating that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1) and that the matter has been closed.","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1019034/000143774925012986/0001437749-25-012986-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"compliance regained"},{"label":"Deficiency","value":"late filing"},{"label":"Rules","value":"5250(c)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}